Prulifloxacin
| Title | Journal |
|---|---|
| Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform. | Toxicology 20170615 |
| Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery. | Journal of chemotherapy (Florence, Italy) 20120201 |
| Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent. | Journal of andrology 20120101 |
| Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial. | Chemotherapy 20120101 |
| Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study. | Biomedical chromatography : BMC 20110801 |
| Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans. | Medical mycology 20110501 |
| Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections. | International journal of antimicrobial agents 20110401 |
| (99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation. | Nuklearmedizin. Nuclear medicine 20110101 |
| [Susceptibility surveillance of clinical isolates to fluoroquinolone antimicrobial agents from 2003 to 2008: post-marketing study of prulifloxacin]. | The Japanese journal of antibiotics 20100601 |
| Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study. | Clinical drug investigation 20100101 |
| In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. | BMC microbiology 20100101 |
| Prulifloxacin ECG study. | Clinical drug investigation 20100101 |
| Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. | International journal of antimicrobial agents 20090901 |
| Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. | International journal of antimicrobial agents 20090601 |
| Prulifloxacin as a trigger of myasthenia gravis. | Journal of the neurological sciences 20090515 |
| Prulifloxacin: clinical studies of a broad-spectrum quinolone agent. | Future microbiology 20090201 |
| Penetration of orally administered prulifloxacin into human prostate tissue. | Clinical drug investigation 20090101 |
| Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. | Drug metabolism and pharmacokinetics 20090101 |
| Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase. | Chemotherapy 20090101 |
| Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901 |
| Capillary electrophoresis-chemiluminescence determination of norfloxacin and prulifloxacin. | Analytica chimica acta 20080815 |
| Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography. | Journal of pharmaceutical and biomedical analysis 20080715 |
| Determination of adenosine disodium triphosphate using prulifloxacin-terbium(III) as a fluorescence probe by spectrofluorimetry. | Analytica chimica acta 20080310 |
| Highly sensitive spectrofluorimetric determination of trace amounts of prulifloxacin using the aluminium(III)-prulifloxacin system. | Luminescence : the journal of biological and chemical luminescence 20080101 |
| Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats. | Drug metabolism and pharmacokinetics 20071001 |
| Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20071001 |
| Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. | European journal of medicinal chemistry 20070701 |
| In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. | International journal of antimicrobial agents 20070601 |
| Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial. | Journal of chemotherapy (Florence, Italy) 20070601 |
| Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis. | International journal of chronic obstructive pulmonary disease 20070301 |
| Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrations. | Drugs in R&D 20070101 |
| Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307 |
| [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens]. | Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20060301 |
| Prulifloxacin: a new antibacterial fluoroquinolone. | Expert review of anti-infective therapy 20060201 |
| Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis. | Pulmonary pharmacology & therapeutics 20060101 |
| Pharmacologic characteristics of prulifloxacin. | Pulmonary pharmacology & therapeutics 20060101 |
| Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. | International journal of antimicrobial agents 20051101 |
| Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin. | Journal of chemotherapy (Florence, Italy) 20050401 |
| Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. | Urologia internationalis 20050101 |
| Penetration of orally administered prulifloxacin into human lung tissue. | Clinical pharmacokinetics 20050101 |
| Prulifloxacin. | Drugs 20040101 |
| Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk. | European journal of pharmacology 20030905 |
| Involvement of multiple transport systems in the disposition of an active metabolite of a prodrug-type new quinolone antibiotic, prulifloxacin. | Drug metabolism and pharmacokinetics 20030101 |
| [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone]. | The Japanese journal of antibiotics 20021201 |
| [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin]. | The Japanese journal of antibiotics 20021201 |
| [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa]. | The Japanese journal of antibiotics 20021201 |
| Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. | Respiration; international review of thoracic diseases 20020101 |
| Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice. | Arzneimittel-Forschung 19961201 |